Haystack Project is a non-profit enabling rare and ultra-rare disease patient advocacy organizations to highlight and address systemic obstacles to patient access. Our core mission is to evolve health care payment and delivery systems to make innovative quality treatments accessible to the patients they were meant to reach.
Haystack Project working with Janet Woodcock on
“Rare Disease Approvals”
The Siegel Rare Neuroimmune Association (SRNA) is first to leverage Haystack Project’s Health Equity in Access to Treatments (“HEAT”) initiative. SRNA is working with Haystack Project to investigate health equity issues in neuroimmune disorders. Specifically, the project seeks to (a) understand variability in access, disease burden and lived experience of patient and caregivers, (b) proactively identify the barriers to diagnosis, specialists and treatments that shape a Black, Latinx, Asian or Native American’s journey, and (c) assess and address the representativeness of the SRNA’s outreach, education and members
Learn more here
Haystack successfully advocated for patients and experts to have an increased role during the FDA review process for treatments for rare diseases!
Read more here.
See What Patient Groups Are Saying About Haystack
Patient Stories
Join Us
About Us
“From the first in-person Haystack meeting, I was so impressed with the quality of speakers and the depth to which they address and seek solutions to access barriers for rare therapies.”
“As a small, rare disease advocacy organization, Haystack helps us stay in the loop on policies that could impact our patients. They keep us informed of the ever-changing landscape around access issues and fill an important role in educating us on various healthcare initiatives.”